Experience of Pain During Oocyte Retrieval- a Comparison Between Two Aspiration Needles

NCT ID: NCT00924885

Last Updated: 2021-01-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

257 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare the pain experience between the patients that have had their transvaginal oocytes retrieval with ultrasound guidance performed with reduced single lumen needle (Vitrolife Sweden AB, Gothenburg) with the patients that have had follicle aspiration needle, 1.4 outer diameter (Vitrolife Sweden AB, Gothenburg), during the procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although the patient is sedated and local analgesia has been given, transvaginal oocytes retrieval with ultrasound guidance can still cause a lot of pain, both during and after the procedure. To reduce the pain, some clinics prefer to use needles as thin as 0.8 mm (outer diameter, OD). A disadvantage with these needles is the increased aspiration time. Therefore a new needle has been developed that has the possibility to reduce pain without a large increase in aspiration time. The needle has a 50 mm long tip with an outer diameter of 0.9 mm. The remaining part of the needle is 300 mm long with an outer diameter of 1.4 mm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thin Follicle Aspiration Needle

Transvaginal oocyte retrieval was performed under local anaesthesia and under guidance of ultrasound with the RN needle that had an outer diameter of 0.9 mm (20 gauge) and inner diameter of 0.6 mm for the last 50 mm from the tip of the needle and an outer diameter of 1.4 mm (17 gauge) and inner diameter of 1 mm for the remaining length of the needle. The puncture procedure was performed according to each clinic's standard routine. Aspiration pressure was kept at a negative pressure between 90 and 120 mmHg.

Group Type EXPERIMENTAL

Swemed Follicle Aspiration Set Reduced Single Lumen

Intervention Type DEVICE

Thin tip to penetrate the tissue

Standard Follicle Aspiration Needle

Transvaginal oocyte retrieval was performed under local anaesthesia and under guidance of ultrasound with the SN needle that had an outer diameter of 1.4 mm (17 gauge) and inner diameter of 1 mm for the remaining length of the needle. or the SN with an outer diameter of 1.4 mm (17 gauge) and inner diameter of 1 mm for the whole length of the needle.

The puncture procedure was performed according to each clinic's standard routine. Aspiration pressure was kept at a negative pressure between 90 and 120 mmHg.

Group Type ACTIVE_COMPARATOR

Swemed Follicle Aspiration Set Single Lumen (1.4 mm)

Intervention Type DEVICE

Standard (1.4 mm) needle to penetrate the tissue

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Swemed Follicle Aspiration Set Reduced Single Lumen

Thin tip to penetrate the tissue

Intervention Type DEVICE

Swemed Follicle Aspiration Set Single Lumen (1.4 mm)

Standard (1.4 mm) needle to penetrate the tissue

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patient has signed an informed consent form before the oocyte retrieval
* The patient is undergoing oocyte retrieval with local anaesthesia
* The patient can speak and understand Swedish

Exclusion Criteria

* The patient has previously participated in Vitrolife-needle-01 study
* The patient has a body mass index ≥35
* Other contra indicator for oocyte retrieval
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vitrolife

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Torbjörn Hillensjö, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Fertility Center Scandinavia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IVF-kliniken Falun

Falun, , Sweden

Site Status

Fertilitetscentrum Göteborg

Gothenburg, , Sweden

Site Status

Reproduktionmedicinskt Center, Universitetssjukhuset MAS

Malmo, , Sweden

Site Status

Fertilitetsenheten K59 Karolinska Universitetssjukhuset, Huddinge

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Wikland M, Blad S, Bungum L, Hillensjo T, Karlstrom PO, Nilsson S. A randomized controlled study comparing pain experience between a newly designed needle with a thin tip and a standard needle for oocyte aspiration. Hum Reprod. 2011 Jun;26(6):1377-83. doi: 10.1093/humrep/der100. Epub 2011 Apr 5.

Reference Type DERIVED
PMID: 21467200 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pubmed/21467200

Link to the published article

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Vitrolife-needle-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Automated Sperm Selection
NCT05240469 RECRUITING NA
Egg Quality Assessment
NCT06609421 SUSPENDED
Use of IMSI in Poor Responders to IVF
NCT02358733 TERMINATED NA